You are not logged in. This means you
CAN ONLY VIEW reports that were published prior to Sunday, October 20, 2024. You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
AFTER MARKET UPDATE - WEDNESDAY, MARCH 16TH, 2022
Previous After Market Report Next After Market Report >>>
|
|
|
DOW |
+518.76 |
34,063.10 |
+1.55% |
|
Volume |
1,350,446,346 |
+15% |
|
Volume |
6,412,863,100 |
+19% |
NASDAQ |
+487.93 |
13,436.55 |
+3.77% |
|
Advancers |
2,516 |
80% |
|
Advancers |
3,264 |
78% |
S&P 500 |
+95.41 |
4,357.86 |
+2.24% |
|
Decliners |
638 |
20% |
|
Decliners |
937 |
22% |
Russell 2000 |
+61.75 |
2,030.72 |
+3.14% |
|
52 Wk Highs |
44 |
|
|
52 Wk Highs |
34 |
|
S&P 600 |
+32.01 |
1,314.99 |
+2.49% |
|
52 Wk Lows |
174 |
|
|
52 Wk Lows |
254 |
|
|
Solid gains from all major market averages came with higher volume coupled with an increase in stocks hitting new 52-week highs. Wednesday's strong session may be considered a late follow-through day confirming a new uptrend (M criteria). Followers of the fact-based investment system know any new buying efforts may be justified only in stocks fitting all key fundamental and technical investment criteria.
|
|
Major Averages Posted Solid Gains With Higher Volume
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
The S&P 500 climbed 2.2%, while the Nasdaq Composite surged 3.8%, with both benchmarks posting their first back-to-back gains in March. The Dow rallied 518 points, turning higher for the month. Volume totals reported were higher than the prior session on the NYSE and on the Nasdaq exchange, revealing an increase in institutional buying demand. Breadth was clearly positive as advancers led decliners by nearly a 4-1 margin on the NYSE and more than 3-1 on the Nasdaq exchange. There were 23 high-ranked companies from the Leaders List that hit new 52-week highs and were listed on the BreakOuts Page, versus 17 on the prior session. New 52-week lows totals contracted yet still solidly outnumbered new 52-week highs totals on the NYSE and on the Nasdaq exchange.
PICTURED: The Dow Jones Industrial Average posted a solid gain with higher volume on Day 15 of the rally since marking the low with a noted "positive reversal" on February 24th. Wednesday's gains coupled with an increase in stocks hitting new 52-week highs may be considered a late follow-through day confirming a new uptrend (M criteria).
U.S. stocks finished firmly higher on Wednesday as Wall Street digested the latest Federal Reserve (Fed) policy decision. As widely expected, the central bank raised its benchmark rate by 25 basis points (0.25%), the first such move since 2018. The Summary of Economic Projections implied policymakers could hike rates six additional times in 2022 in an effort to combat persisting price pressures. Fed Chair Jerome Powell anticipated inflation would peak mid-year, but signaled that officials could tighten monetary policy more quickly, if appropriate, noting that the U.S. economy was positioned to withstand the adjustments. Optimism over potential Russia-Ukraine ceasefire talks also buoyed risk appetite, with both sides offering upbeat comments.
Treasuries weakened following the Fed decision, with the yield curve flattening. The 10-year note yield climbed three basis points (0.03%) to 2.18%, while the two-year note yield spiked seven basis points (0.07%) to 1.92%, with both near their highest level since mid-2019. In commodities, West Texas Intermediate crude dropped 1.4% to $95.07/barrel. On the data front, retail sales rose a smaller-than-anticipated 0.3% in February, compared to January’s upwardly revised 4.9% gain.
Nine of 11 S&P 500 sectors closed in positive territory, with Energy and Utilities the lone laggards. Consumer Discretionary and Information Technology sectors outperformed amid strength in growth-oriented names. In corporate news, Micron Technology Inc. (MU +8.97%) and Starbucks Corp (SBUX +5.16%), respectively, on the heels of analyst upgrades. Also, Alibaba Group Holdings Ads (BABA +26.76%), Baidu Inc Ads (BIDU +39.20%), and JD.com (JD +39.36%) were among the day's standout gainers after the Chinese government's financial stability and development committee stressed "market friendly policies".
|
Kenneth J. Gruneisen started out as a licensed stockbroker in August 1987, a couple of months prior to the historic stock market crash that took the Dow Jones Industrial Average down -22.6% in a single day. He has published daily fact-based fundamental and technical analysis on high-ranked stocks online for two decades. Through FACTBASEDINVESTING.COM, Kenneth provides educational articles, news, market commentary, and other information regarding proven investment systems that work in good times and bad.
Comments contained in the body of this report are technical opinions only and are not necessarily those of Gruneisen Growth Corp. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. Our firm, employees, and customers may effect transactions, including transactions contrary to any recommendation herein, or have positions in the securities mentioned herein or options with respect thereto. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. |
|
|
Financial, Retail, and Tech Indexes Rose
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
The Broker/Dealer Index ($XBD +5.09%) and Bank Index ($BKX +3.63%) both notched influential gains on Wednesday while the Retail Index ($RLX +2.56%) also posted a solid gain. The tech sector had a positive bias as the Semiconductor Index ($SOX +5.03%), Networking Index ($NWX +2.35%), and Biotech Index ($BTK +3.39%) posted unanimous gains. Meanwhile energy-linked groups were mixed as the Oil Services Index ($OSX -1.52%) fell while the Integrated Oil Index ($XOI +0.42%) edged higher, and the Gold & Silver Index ($XAU -0.03%) finished flat. PICTURED: The Integrated Oil Index ($XOI +0.42%) has recently pulled back from multi-year highs.
Oil Services |
$OSX |
72.26 |
-1.12 |
-1.52% |
+37.07% |
Integrated Oil |
$XOI |
1,446.72 |
+6.01 |
+0.42% |
+22.79% |
Semiconductor |
$SOX |
3,340.06 |
+159.83 |
+5.03% |
-15.36% |
Networking |
$NWX |
853.34 |
+19.60 |
+2.35% |
-12.12% |
Broker/Dealer |
$XBD |
469.93 |
+22.76 |
+5.09% |
-3.48% |
Retail |
$RLX |
3,755.10 |
+93.75 |
+2.56% |
-11.15% |
Gold & Silver |
$XAU |
153.08 |
-0.05 |
-0.03% |
+15.57% |
Bank |
$BKX |
130.31 |
+4.57 |
+3.63% |
-1.45% |
Biotech |
$BTK |
4,892.59 |
+160.47 |
+3.39% |
-11.34% |
|
|
|
6th Straight Gain Leaves Regeneron Near Record High
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
Regeneron Pharmaceuticals Inc (REGN +$12.05 or +1.81% to $677.98) posted a 6th consecutive gain today with near average volume, wedging above its December high. Its color code was changed to yellow with new pivot point cited based on its 12/14/21 high plus 10 cents. REGN found support above its 200 DMA line ($609) during its consolidation in recent months and it has made steady progress since last covered in greater detail on 3/02/22 with an annotated graph under the headline, "Still Quietly Consolidating Above 200 DMA Line". Subsequent gains above the pivot point backed by at least +40% above average volume may trigger a technical buy signal.
The high-ranked DRUGS - Biotechnology firm reported earnings +149% on +104% sales revenues for the Dec '21 quarter versus the year ago period. That marked its 6th quarterly comparison above the +25% minimum earnings guideline (C criteria) and with a strong sales revenues growth rate. Its annual earnings (A criteria) growth has been strong. It has a highest possible 99 Earnings Per Share Rating.
There are 2,746 top-rated funds that own its shares as of Dec '21, up from 2,376 in Dec '20, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 1.2 is an unbiased indication its shares have been under slight accumulation over the past 50 days. REGN completed a Secondary Offering on 5/28/20. There are 97.1 million shares in the public float (S criteria) which can contribute to greater volatility in the event of institutional buying or selling.
|
|
Color Codes Explained :
Y - Better candidates highlighted by our
staff of experts. G - Previously featured
in past reports as yellow but may no longer be buyable under the
guidelines.
***Last / Change / Volume data in this table is the closing quote data***
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE (%Change) |
Day High |
Volume (% DAV) (% 50 day avg vol) |
52 Wk Hi % From Hi |
Featured Date |
Price Featured |
Pivot Featured |
Max Buy |
REGN
-
NASDAQ
Regeneron Pharmaceutical
DRUGS - Biotechnology
|
$677.98
|
+12.05
1.81% |
$678.68
|
802,842 106.48% of 50 DAV
50 DAV is 754,000
|
$686.62 -1.26%
|
3/14/2022
|
$647.95
|
PP = $673.96
|
MB = $707.66
|
Most Recent Note - 3/15/2022 4:49:12 PM
Y - Posted a 5th consecutive gain today with near average volume, approaching its December highs. Color code was changed to yellow with new pivot point cited based on its 12/14/21 high plus 10 cents. Subsequent gains above the pivot point backed by at least +40% above average volume may trigger a technical buy signal Recently found support above its 200 DMA line ($608). Prior lows in the $592-596 area define important near-term support. Disciplined investors know to avoid new buying efforts until a confirmed rally with follow through day from the major averages (M criteria) under the fact-based investment system's strict rules.
>>> FEATURED STOCK ARTICLE : Still Quietly Consolidating Above 200 DMA Line - 3/2/2022 |
View all notes |
Set NEW NOTE alert |
Company Profile |
SEC
News |
Chart |
Request a new note
C
A
S
I |
TGH
-
NYSE
Textainer Group Holdings
TRANSPORTATION - Logistics
|
$38.03
|
+1.11
3.01% |
$38.21
|
330,731 70.82% of 50 DAV
50 DAV is 467,000
|
$41.89 -9.21%
|
1/31/2022
|
$36.68
|
PP = $41.34
|
MB = $43.41
|
Most Recent Note - 3/15/2022 4:50:25 PM
G - Sputtering below its 50 DMA line ($37.54) and it faces resistance due to overhead supply up to the $41 level. Important near-term support to watch is its 200 DMA line ($35) and prior lows. Any violations would raise serious concerns and trigger technical sell signals. Fundamentals remain strong. See the latest FSU analysis for more details and an annotated graph.
>>> FEATURED STOCK ARTICLE : Slumped Below 50-Day Moving Average Line Toward Prior Lows - 3/14/2022 |
View all notes |
Set NEW NOTE alert |
Company Profile |
SEC
News |
Chart |
Request a new note
C
A
S
I |
HWKN
-
NASDAQ
Hawkins Inc
CHEMICALS - Basic Chemicals
|
$44.80
|
-0.94
-2.06% |
$46.24
|
99,617 160.67% of 50 DAV
50 DAV is 62,000
|
$47.13 -4.94%
|
2/3/2022
|
$39.81
|
PP = $41.07
|
MB = $43.12
|
Most Recent Note - 3/15/2022 4:46:11 PM
G - Hovering near its all-time high, extended from the previously noted base. Prior highs in the $40 area and its 50 DMA line define important near-term support to watch on pullbacks. See the latest FSU analysis for more details and a new annotated graph.
>>> FEATURED STOCK ARTICLE : Hovering Near High After Rising From Prior Base - 3/15/2022 |
View all notes |
Set NEW NOTE alert |
Company Profile |
SEC
News |
Chart |
Request a new note
C
A
S
I |
IMXI
-
NASDAQ
International Money Exp
Financial Svcs-Specialty
|
$20.30
|
+1.96
10.69% |
$20.63
|
1,037,228 403.59% of 50 DAV
50 DAV is 257,000
|
$18.96 7.07%
|
3/8/2022
|
$18.64
|
PP = $19.06
|
MB = $20.01
|
Most Recent Note - 3/16/2022 12:59:13 PM
Y - Powering above its pivot point to a new high all-time high. Highlighted in yellow in the 3/08/22 mid-day report with pivot point cited based on its 8/30/21 high plus 10 cents. Through Dec '21 its quarterly and annual earnings (C and A criteria) history has been strong. Small supply of only 32.2 million shares in the public float (S criteria) can contribute to greater price volatility in the event of institutional buying or selling. Disciplined investors know to avoid new buying efforts until a confirmed rally with follow through day from the major averages (M criteria) under the fact-based investment system's strict rules.
>>> FEATURED STOCK ARTICLE : Volume-Driven Gains Challenged All-Time High - 3/8/2022 |
View all notes |
Set NEW NOTE alert |
Company Profile |
SEC
News |
Chart |
Request a new note
C
A
S
I |
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
This site is not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to Premium Membership Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 1-800-965-8307
or 954-785-1121.
|
|
|